ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,988Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 1290

$555K Total Retail Price of All Prescriptions

Rank: 165 out of 1290

350 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 9,245 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 426 384 1 1
OMEPRAZOLE 384 355 2 2
METOPROLOL SUCCINATE 309 296 3 14
LISINOPRIL 275 247 4 5
FENOFIBRATE 231 208 5 98
ATORVASTATIN CALCIUM 221 220 6 23
CRESTOR 218 205 7 17
ATENOLOL 215 182 8 18
ALPRAZOLAM 214 201 9 47
METFORMIN HCL 202 199 10 10
LEVOTHYROXINE SODIUM 196 173 11 4
AMLODIPINE BESYLATE 187 163 12 3
NEXIUM 176 172 13 34
FLUTICASONE PROPIONATE 160 135 14 26
FUROSEMIDE 152 137 15 9
DIOVAN 118 110 16 53
LOSARTAN POTASSIUM 113 109 17 19
TEMAZEPAM 113 113 17 71
ENALAPRIL MALEATE 109 109 19 62
AZITHROMYCIN 107 95 20 61
METOPROLOL TARTRATE 105 95 21 7
CLOPIDOGREL 101 101 22 24
PANTOPRAZOLE SODIUM 97 97 23 48
BENICAR HCT 96 96 24 241
ESCITALOPRAM OXALATE 95 88 25 63
SERTRALINE HCL 92 84 26 36
HYDROCHLOROTHIAZIDE 91 77 27 20
GLIMEPIRIDE 87 85 28 57
LANSOPRAZOLE 87 69 28 181
PLAVIX 84 84 30 32
RANITIDINE HCL 82 70 31 49
VERAPAMIL ER 82 82 31 259
CLORAZEPATE DIPOTASSIUM 81 81 33 477
DIOVAN HCT 80 80 34 112
ZOLPIDEM TARTRATE 78 71 35 15
CARVEDILOL 74 74 36 12
VYTORIN 73 69 37 293
BENICAR 73 65 37 205
ALENDRONATE SODIUM 73 73 37 39
CLONAZEPAM 72 67 40 170
ACTOS 71 63 41 182
DONEPEZIL HCL 68 68 42 13
TEKTURNA 68 68 42 426
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 65 44 92
POTASSIUM CHLORIDE 65 51 44 35
MEGESTROL ACETATE 63 63 R 46 198
PRAVASTATIN SODIUM 59 48 47 42
TAMSULOSIN HCL 58 58 48 11
CLONIDINE HCL 57 45 49 66
DIGOXIN 56 56 50 51
FOLIC ACID 56 44 50 188
IBUPROFEN 56 48 50 74
ISOSORBIDE MONONITRATE ER 55 55 53 58
MECLIZINE HCL 53 53 54 159
PAROXETINE HCL 52 39 55 84
GABAPENTIN 51 44 56 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.